FT4/FT3 ratio: A novel biomarker predicts coronary microvascular dysfunction (CMD) in euthyroid INOCA patients
BackgroundIschemia and no obstructive coronary artery disease (INOCA) patients who presented coronary microvascular dysfunction (CMD) demonstrate a poor prognosis, yet the risk factors for CMD remain unclear. Subtle changes in thyroid hormone levels within the normal range, especially the free thyro...
Main Authors: | Han Zhang, Wenliang Che, Kuangyu Shi, Yan Huang, Chong Xu, Mengyu Fei, Xin Fan, Jiajia Zhang, Xueping Hu, Fan Hu, Shanshan Qin, Xiaoying Zhang, Qingqing Huang, Fei Yu |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-09-01
|
Series: | Frontiers in Endocrinology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fendo.2022.1021326/full |
Similar Items
-
Clinical aspects of ischemia with no obstructive coronary artery disease (INOCA)
by: Alexander Polyak, et al.
Published: (2024-01-01) -
A Left Ventricular Mechanical Dyssynchrony-Based Nomogram for Predicting Major Adverse Cardiac Events Risk in Patients With Ischemia and No Obstructive Coronary Artery Disease
by: Han Zhang, et al.
Published: (2022-03-01) -
ANOCA/INOCA/MINOCA: Open artery ischemia
by: Carl J. Pepine
Published: (2023-02-01) -
Molecular Hallmarks of Ischemia with Non-Obstructive Coronary Arteries: The “INOCA versus Obstructive CCS” Challenge
by: Alice Bonanni, et al.
Published: (2022-03-01) -
Case report: Repeat coronary function testing in women with ischemia and no obstructive coronary artery disease
by: Nissi Suppogu, et al.
Published: (2023-07-01)